Early initiation of beta blockade in heart failure: issues and evidence.

Item

http://www.wikidata.org/entity/Q36287752

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Early initiation of beta blockade in heart failure: issues and evidence.

@ast

Early initiation of beta blockade in heart failure: issues and evidence.

@en

type

Item

label

Early initiation of beta blockade in heart failure: issues and evidence.

@ast

Early initiation of beta blockade in heart failure: issues and evidence.

@en

prefLabel

Early initiation of beta blockade in heart failure: issues and evidence.

@ast

Early initiation of beta blockade in heart failure: issues and evidence.

@en

P1476

Early initiation of beta blockade in heart failure: issues and evidence.

@en

P2093

Randall E Williams

http://www.w3.org/2001/XMLSchema#string

P2860

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

Beta-blockade in heart failure: a comparison of carvedilol with metoprolol

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

Effect of carvedilol on survival in severe chronic heart failure.

Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study.

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

P304

520-8; quiz 529-30

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1524-6175.2005.04273.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

240120350

http://www.w3.org/2001/XMLSchema#string

P698

16227771

http://www.w3.org/2001/XMLSchema#string

P921

heart failure